全球亚磷酰胺市场按产品类型、应用、最终用户和地区划分

2025 年全球亚磷酰胺市场规模估计为 10.128 亿美元，预计到 2032 年将达到 16.803 亿美元，2025 年至 2032 年的年复合成长率（CAGR）为 7.5%。

数字。 2025年全球市场占有率（%）

亚磷酰胺是 DNA 和 RNA 分子合成的基石，在生物技术和医学等不同领域中发挥着至关重要的作用。该化合物是实现可控且精确的寡核苷酸合成的关键构件。其意义在于促进合成过程中核苷酸的逐步组装，为研究人员和工业界提供客製化DNA和RNA序列以用于各种应用的能力。亚磷酰胺市场的特点是研究、诊断和治疗应用领域对客自订寡核苷酸的需求不断增加。生技公司、製药商和学术机构是主要消费者，凸显了这种化合物的广泛应用范围。技术进步和合成方法的创新不断推动市场的扩张。客自订合成服务已变得流行，可以根据特定的研究或治疗要求进行生产。

法规遵循对于亚磷酰胺市场至关重要，公司确保在核酸产品的开发和生产中遵守严格的品质标准。随着分子研究的进步和精准医疗的日益突出，亚磷酰胺仍然处于领先地位，为基因组学、诊断学和治疗应用的发展做出了巨大贡献。

市场动态：

亚磷酰胺市场在生物技术和製药领域发挥关键作用，是 DNA 和 RNA 分子合成的基本组成部分。亚磷酰胺是促进寡核苷酸的可控和精确合成的基石。市场成长的动力来自于研究、诊断和治疗应用领域对客製化寡核苷酸日益增长的需求。主要消费者包括生物技术公司、製药商和学术机构，证明了其应用的多样性。持续的技术进步和创新的合成方法正在帮助扩大市场，突出自订合成服务以满足特定需求的寡核苷酸。在基于核酸的产品开发中，严格遵守监管标准对于确保品质至关重要。

本研究的主要特点

• 本报告对全球亚磷酰胺市场进行了详细分析，并以 2024 年为基准年，展示了预测期（2025-2032 年）的市场规模和复合年增长率。
• 它还强调了各个领域的潜在商机，并说明了该市场的有吸引力的投资提案矩阵。
• 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的重要见解。
• 研究报告根据公司亮点、产品系列、主要成就、财务表现和策略等参数，概述了全球亚磷酰胺市场的主要企业，包括 BioAutomation Corporation、Merck KGaA、Sigma-Aldrich（现为默克集团公司 MilliporeSigma 的一部分）、LGC Biosearch Technologies、赛默飞世尔科技、Biochemistry Inc.、GenkT Ltd., 东林科技公司、东林科技公司发展有限公司、东林科技公司发展有限公司、非东林科技公司。
• 本报告的见解将使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
• 全球亚磷酰胺市场报告针对该行业的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
• 可以透过用于分析全球亚磷酰胺市场的各种策略矩阵来促进相关人员的决策。

目录

第一章 调查目的与前提条件

• 研究目标
• 先决条件
• 简称

第二章 市场展望

• 报告描述
  • 市场定义和范围
• 执行摘要
• Coherent Opportunity Map（COM）

第三章市场动态、法规与趋势分析

• 市场动态
  • 固相DNA合成的技术进步。
  • DNA合成成本高成本
  • 扩展DNA合成的诊断应用
• 主要亮点
• 监管情景
• 近期动态
• PEST分析
• 波特分析
• 产品发布
• 合併、收购和合作

4. 全球亚磷酰胺市场-冠状病毒（COVID-19）大流行的影响

• COVID-19流行病学
• 供需侧分析
• 经济影响

5. 2020 年至 2032 年全球亚磷酰胺市场（依产品类型）

• DMT保护的亚磷酰胺
• 酸保护亚磷酰胺
• 酰胺基砌块
• DNA/RNA亚磷酰胺

6. 2020 年至 2032 年全球亚磷酰胺市场（依应用）

• DNA/RNA定序
• 基因表现分析
• 基因检测
• 药物研发

7. 全球亚磷酰胺市场（依最终用户划分），2020 年至 2032 年

• 生技公司
• 製药公司
• 学术研究所

8. 2020 年至 2032 年全球亚磷酰胺市场（按地区划分）

• 北美洲
• 欧洲
• 亚太地区
• 拉丁美洲
• 中东
• 非洲

第九章 竞争态势

• 公司简介
  • Glen Research
  • ChemGenes Corporation
  • Link Technologies Ltd.
  • BioAutomation Corporation
  • Merck KGaA
  • Sigma-Aldrich（now part of MilliporeSigma, a Merck Group company）
  • LGC Biosearch Technologies
  • Thermo Fisher Scientific
  • Biosynthesis Inc.
  • ATDBio Ltd.
  • Genscript Biotech Corporation
  • Expedeon AG
  • Wuxi Donglin Sci &Tech Development Co., Ltd.
  • Bio-Synthesis Inc.
  • ChemGenes Corporation

第 10 章 章节

• 参考
• 调查方法
• 关于出版商

Global Phosphoramidite Market is estimated to be valued at USD 1,012.8 Mn in 2025 and is expected to reach USD 1,680.3 Mn by 2032, growing at a compound annual growth rate (CAGR) of 7.5% from 2025 to 2032.

Figure. Global Phosphoramidite Market Share (%), By Region 2025

Phosphoramidite stands as a cornerstone in the synthesis of DNA and RNA molecules, playing a pivotal role in diverse fields such as biotechnology and pharmaceuticals. This compound serves as a crucial building block, enabling controlled and precise oligonucleotide synthesis. Its significance lies in facilitating the stepwise assembly of nucleotides during the synthesis process, offering researchers and industries the ability to customize DNA and RNA sequences for various applications. The phosphoramidite market is characterized by a growing demand for custom oligonucleotides, spanning research, diagnostics, and therapeutic applications. Biotechnology companies, pharmaceutical manufacturers, and academic institutions are key consumers, emphasizing the compound's broad spectrum of applications. Technological advancements and innovations in synthesis methods continually drive market expansion. Custom synthesis services have gained prominence, allowing tailored production to meet specific research or therapeutic requirements.

Regulatory compliance is integral to the phosphoramidite market, with companies ensuring adherence to stringent quality standards in the development and production of nucleic acid-based products. As molecular research advances and precision medicine gains prominence, Phosphoramidite remains at the forefront, contributing significantly to the evolution of genomics, diagnostics, and therapeutic applications.

Market Dynamics:

The phosphoramidite market plays a crucial role in the biotechnology and pharmaceutical sectors, serving as a fundamental element in the synthesis of DNA and RNA molecules. It acts as a cornerstone, facilitating controlled and precise oligonucleotide synthesis. The market's growth is propelled by a rising demand for customized oligonucleotides across research, diagnostics, and therapeutic applications. Key consumers include biotechnology firms, pharmaceutical manufacturers, and academic institutions, underscoring its diverse applications. Ongoing technological advancements and innovative synthesis methods contribute to the market's expansion, with custom synthesis services gaining prominence for tailoring oligonucleotides to specific needs. Strict adherence to regulatory standards is paramount to ensuring quality in the development of nucleic acid-based products.

Key features of the study:

• This report provides in-depth analysis of the global phosphoramidite market, and provides market size (US$ Mn) and compound annual growth rate (CAGR %) for the forecast period (2025-2032), considering 2024 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global phosphoramidite market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies - Key companies covered as a part of this study include Glen Research, ChemGenes Corporation, Link Technologies Ltd., BioAutomation Corporation, Merck KGaA, Sigma-Aldrich (now part of MilliporeSigma, a Merck Group company), LGC Biosearch Technologies, Thermo Fisher Scientific, Biosynthesis Inc., ATDBio Ltd., Genscript Biotech Corporation, Expedeon AG, Wuxi Donglin Sci & Tech Development Co., Ltd., Bio-Synthesis Inc., and ChemGenes Corporation.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global phosphoramidite market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global phosphoramidite market.

Detailed Segmentation:

• Global Phosphoramidite Market, By Product Type
  • DMT-protected Phosphoramidites
  • Acid-protected Phosphoramidites
  • Amidite Building Blocks
  • DNA/RNA Phosphoramidite
• Global Phosphoramidite Market, By Application
  • DNA/RNA Sequencing
  • Gene Expression Analysis
  • Genetic Testing
  • Drug Discovery
• Global Phosphoramidite Market, By End User
  • Biotechnology Companies
  • Pharmaceutical Companies
  • Academic and Research Institutes
• Global Phosphoramidite Market, By Region
  • North America
  • Europe
  • Asia Pacific
  • Central & South America
  • Middle East and Africa
• Company Profiles
  • Glen Research
  • ChemGenes Corporation
  • Link Technologies Ltd.
  • BioAutomation Corporation
  • Merck KGaA
  • Sigma-Aldrich (now part of MilliporeSigma, a Merck Group company)
  • LGC Biosearch Technologies
  • Thermo Fisher Scientific
  • Biosynthesis Inc.
  • ATDBio Ltd.
  • Genscript Biotech Corporation
  • Expedeon AG
  • Wuxi Donglin Sci & Tech Development Co., Ltd.
  • Bio-Synthesis Inc.
  • ChemGenes Corporation

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snippet, By Product Type
  • Market Snippet, By Application
  • Market Snippet, By End User
  • Market Snippet, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Technological advancements in solid-phase DNA synthesis
  • High costs associated with DNA synthesis
  • Growing diagnostic applications of DNA synthesis
• Key Highlights
• Regulatory Scenario
• Recent Trends
• PEST Analysis
• PORTER's Analysis
• Product Launches
• Mergers, Acquisitions, and Collaborations

4. Global Phosphoramidite Market - Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Global Phosphoramidite Market, By Product Type, 2020-2032, (US$ Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• DMT-protected Phosphoramidites
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Acid-protected Phosphoramidites
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Amidite Building Blocks
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• DNA/RNA Phosphoramidite
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

6. Global Phosphoramidite Market, By Application, 2020-2032, (US$ Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• DNA/RNA Sequencing
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Gene Expression Analysis
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Genetic Testing
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Drug Discovery
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

7. Global Phosphoramidite Market, By End User, 2020-2032, (US$ Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Biotechnology Companies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Pharmaceutical Companies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Academic and Research Institutes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

8. Global Phosphoramidite Market, By Region, 2020-2032, (US$ Mn)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Region, 2021 -2032
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
    • U.S.
    • Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032,(US$ Mn)
    • North Africa
    • Central Africa
    • South Africa

9. Competitive Landscape

• Company Profile
  • Glen Research
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • ChemGenes Corporation
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • Link Technologies Ltd.
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • BioAutomation Corporation
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • Merck KGaA
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • Sigma-Aldrich (now part of MilliporeSigma, a Merck Group company)
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • LGC Biosearch Technologies
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • Thermo Fisher Scientific
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • Biosynthesis Inc.
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • ATDBio Ltd.
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • Genscript Biotech Corporation
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • Expedeon AG
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • Wuxi Donglin Sci & Tech Development Co., Ltd.
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • Bio-Synthesis Inc.
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • ChemGenes Corporation
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
• Analyst Views

10. Section

• References
• Research Methodology
• About us